California Public Employees Retirement System trimmed its stake in Acadia Healthcare Company Inc (NASDAQ:ACHC) by 2.7% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 166,872 shares of the company’s stock after selling 4,628 shares during the period. California Public Employees Retirement System owned 0.19% of Acadia Healthcare worth $6,827,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in ACHC. Alpine Woods Capital Investors LLC bought a new position in shares of Acadia Healthcare in the 2nd quarter worth $153,000. New Jersey Better Educational Savings Trust bought a new position in shares of Acadia Healthcare in the 2nd quarter worth $205,000. Cubist Systematic Strategies LLC acquired a new position in Acadia Healthcare during the 1st quarter valued at about $255,000. Bbva Compass Bancshares Inc. acquired a new position in Acadia Healthcare during the 2nd quarter valued at about $259,000. Finally, BNP Paribas Arbitrage SA increased its position in Acadia Healthcare by 118.3% during the 2nd quarter. BNP Paribas Arbitrage SA now owns 8,425 shares of the company’s stock valued at $345,000 after buying an additional 4,566 shares in the last quarter.

Acadia Healthcare stock opened at $33.30 on Friday. The company has a current ratio of 1.24, a quick ratio of 1.24 and a debt-to-equity ratio of 1.20. The stock has a market cap of $3.11 billion, a price-to-earnings ratio of 14.48, a PEG ratio of 1.26 and a beta of 0.64. Acadia Healthcare Company Inc has a fifty-two week low of $26.92 and a fifty-two week high of $45.27.

Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings results on Monday, July 30th. The company reported $0.70 earnings per share for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.70. The business had revenue of $765.70 million for the quarter, compared to the consensus estimate of $767.93 million. Acadia Healthcare had a return on equity of 7.93% and a net margin of 7.52%. The company’s quarterly revenue was up 5.5% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.66 EPS. On average, research analysts forecast that Acadia Healthcare Company Inc will post 2.52 earnings per share for the current year.

ACHC has been the topic of several recent analyst reports. Zacks Investment Research raised Acadia Healthcare from a “hold” rating to a “buy” rating and set a $48.00 target price on the stock in a research report on Tuesday, July 24th. Jefferies Financial Group upped their target price on Acadia Healthcare from $44.00 to $47.00 and gave the company a “buy” rating in a research report on Tuesday, July 31st. BidaskClub raised Acadia Healthcare from a “hold” rating to a “buy” rating in a research report on Monday, June 18th. Mizuho set a $37.00 target price on Acadia Healthcare and gave the company a “hold” rating in a research report on Tuesday, August 28th. Finally, BMO Capital Markets lowered Acadia Healthcare from an “outperform” rating to a “market perform” rating and set a $45.00 target price on the stock. in a research report on Wednesday, August 1st. Two equities research analysts have rated the stock with a sell rating, five have issued a hold rating and nine have given a buy rating to the company. Acadia Healthcare has a consensus rating of “Hold” and an average price target of $44.36.

In other Acadia Healthcare news, Director Reeve B. Waud sold 8,135 shares of the business’s stock in a transaction dated Thursday, July 26th. The stock was sold at an average price of $45.00, for a total transaction of $366,075.00. Following the sale, the director now owns 14,213 shares in the company, valued at approximately $639,585. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 2.50% of the stock is currently owned by insiders.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities. The company operates acute inpatient psychiatric facilities, which offer evaluation and crisis stabilization of patients with severe psychiatric diagnoses; specialty treatment facilities, including residential recovery facilities, eating disorder facilities, and comprehensive treatment centers that provide continuum care for adults with addictive disorders and co-occurring mental disorders; and residential treatment centers, which treat patients with behavioral disorders in a non-hospital setting, including outdoor programs.

Recommended Story: Inflation

Want to see what other hedge funds are holding ACHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Acadia Healthcare Company Inc (NASDAQ:ACHC).

Institutional Ownership by Quarter for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.